Immunization Record – Room for Improvement?

From Apr 21 to 28, it’s National Immunization Awareness Week in Canada. So I think it is timely to share this story on immunization record. I have received few “threatening” letters from Public Health that my daughter would soon be expelled from school because her immunization records were incomplete.

Continue reading Immunization Record – Room for Improvement?

Advertisements

Nabilone Shortage or a Fabricated Reason for Medical Cannibis?

I recently blogged about the drug shortage of Nabilone which I thought has resolved. So when I heard patients having difficulty with getting the medication again, I picked up the phone and started calling.

Continue reading Nabilone Shortage or a Fabricated Reason for Medical Cannibis?

SUSTAIN-6: Another Medication for Diabetes with Cardiovascular Benefits?

Semaglutide (Ozempic) recently received its Notice of Compliance from Health Canada and is therefore now available for Canadians with Type 2 diabetes. So it only makes sense to take a closer look at its evidence, particularly the evidence for its cardiovascular benefits which was studied in SUSTAIN-6 and published in New England Journal of Medicine in 2016..

Continue reading SUSTAIN-6: Another Medication for Diabetes with Cardiovascular Benefits?

When your patients can’t afford their medications

When patients indicate they cannot afford the medications you have prescribed for them, do you know what options are available to explore? Often prescribers may be quick to ask about compassionate programs or free supplies that are available to explore, but they are rarely the solution to a permanent problem.

Continue reading When your patients can’t afford their medications

Why new drugs are not sexy yet?

When a new medication is available, there is often a lot of excitement and hype about how a new option may bring hope to a medical condition. The new medication may offer breakthrough in improving important clinical outcomes (e.g. improving survival, preventing disease complications and significantly offering better quality of life for patients).  But before we jump on the bandwagon to start prescribing a new medication, here are few considerations the sales rep may not be quick to highlight or share.

Continue reading Why new drugs are not sexy yet?

No! Taking two Basal Insulins is not OK.

Insulin is considered a high risk medication for which serious adverse events can occur if an incorrect dose is inadvertently given. That is why we have implemented double check systems at many points of care or processes in hope to minimize and prevent these potentially serious and fatal errors.

Continue reading No! Taking two Basal Insulins is not OK.

Constructive Feedback – Not as Easy to Give or Receive

As much as we try to sugarcoat any negative message with the term “constructive feedback”, it is never easy to communicate.  If your student is not doing well or you want to highlight an area that may require improvement, it is always difficult to deliver it well.

Continue reading Constructive Feedback – Not as Easy to Give or Receive